Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.44M Buy
+150,000
New +$2.67M ﹤0.01% 4932
2024
Q2
Sell
-68,600
Closed -$1.76M 10188
2024
Q1
$1.76M Buy
+68,600
New +$1.72M ﹤0.01% 4075
2022
Q1
Sell
-45,360
Closed -$1.3M 10989
2021
Q4
$1.3M Buy
+45,360
New +$1.48M ﹤0.01% 4155
2021
Q2
Sell
-433,739
Closed -$16.3M 9885
2021
Q1
$16.3M Buy
+433,739
New +$18.5M 0.01% 1577

Other funds holding XP

UBS Group's XP Position: Q2 2026 in Review

UBS Group increased its XP (XP) stake by 17% in Q2 2026, buying an estimated $4.48M and bringing the position to 1,724,803 shares worth $28M. The position accounts for ﹤0.01% of the portfolio, ranked #2332.

UBS Group first reported a position in XP in Q4 2019 and has held it in 27 quarters since. The position peaked at $28.1M in Q1 2026. 320 funds tracked by Wall St. Rank hold XP as of Q2 2026.

  • UBS Group held 1,724,803 shares of XP worth $28M as of Q2 2026.
  • UBS Group bought 251,295 XP shares in Q2 2026, an estimated $4.48M.
  • XP made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #2332 holding.
  • UBS Group first reported a position in XP in Q4 2019 and has held it in 27 quarters since.
  • UBS Group's XP position peaked at $28.1M in Q1 2026.
  • 320 funds tracked by Wall St. Rank held XP as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.